Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors

Johnson, Douglas S, Weerapana, Eranthie, Cravatt, Benjamin F·2010·Future Medicinal Chemistry
DOI 10.4155/fmc.10.21

Cited by (425)

Items 201–300 of 425

  1. Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation
    Thuy Nguyen, Robert A. Coover, Jenson Verghese, Richard G. Moran, Keith C. Ellis · 2014 · ACS Medicinal Chemistry Letters
  2. Inhibition of Aggrecanases as a Therapeutic Strategy in Osteoarthritis
    Jamal El Bakali, Hélène Gras‐Masse, Lucie Maingot, Benoit P. Deprez, Julie Dumont, Florence Leroux, Rebecca F. Deprez-Poulain · 2014 · Future Medicinal Chemistry
  3. Reversible covalent direct thrombin inhibitors
    Mohanram Sivaraja, Nicola Pozzi, Matthew Rienzo, Kenneth Lin, Timothy P. Shiau, Daniel M. Clemens, Lev Igoudin, Piotr Zalicki, Stephanie Chang, M. Angels Estiarte et al. · 2018 · PLoS ONE
  4. Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition
    Letitia Shunmugam, Mahmoud E. S. Soliman · 2018 · RSC Advances
  5. Bacteriostatic Effects of Apatite-Covered Ag/AgBr/TiO2 Nanocomposite in the Dark: Anomaly in Bacterial Motility
    Seyedsaeid Ahmadvand, Mohammadreza Elahifard, Mehdi Jabbarzadeh, Amir Mirzanejad, Kathryn J. Pflughoeft, Bahman Abbasi, Behrooz Abbasi · 2019 · The Journal of Physical Chemistry B
  6. Converting (E)‐(Hetero)arylethanesulfonyl Fluorides to (Z)‐(Hetero)arylethanesulfonyl Fluorides Under Light Irradiation
    Yumei Huang, Shi‐Meng Wang, Jing Leng, Balakrishna Moku, Chuang Zhao, Njud Saleh Alharbi, Hua‐Li Qin · 2019 · European Journal of Organic Chemistry
  7. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells
    Simona Daniele, Elisabetta Barresi, Elisa Zappelli, Luciana Marinelli, Ettore Novellino, Federico Da Settimo, Sabrina Taliani, Maria Letizia Trincavelli, Claudia Martini · 2016 · Oncotarget
  8. Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors
    Liqiang Han, Yanzhao Wen, Ridong Li, Bo Xu, Zemei Ge, Xin Wang, Tieming Cheng, Jingrong Cui, Runtao Li · 2017 · Bioorganic & Medicinal Chemistry
  9. Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors
    Wenjie Zhang, Heyuan Bai, Liqiang Han, Han Zhang, Bo Xu, Jingrong Cui, Xin Wang, Zemei Ge, Runtao Li · 2018 · Bioorganic & Medicinal Chemistry Letters
  10. Inhibition of metabolic cooperation in Chinese hamster cells by organochlorine pesticides.
    Masaaki Kurata, K Hirose, M Umeda · 1982 · PubMed
  11. Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins
    Yang, Yanou, Shu, Yue-Zhong, Humphreys, W. Griffith · 2016 · Chemical Research in Toxicology
  12. Biomimetic Synthesis and Chemical Proteomics Reveal the Mechanism of Action and Functional Targets of Phloroglucinol Meroterpenoids
    Amy K. Bracken, Colby E. Gekko, Nina O. Suss, Emma E. Lueders, Qi Cui, Qin Fu, Andy C. W. Lui, Elizabeth T. Anderson, Sheng Zhang, Mikail E. Abbasov · 2024 · Journal of the American Chemical Society
  13. Efficient and Facile Synthesis of Acrylamide Libraries for Protein-Guided Tethering
    Charlotte E. Allen, Peter R. Curran, Andrew S. Brearley, Valerie Boissel, Lilya Sviridenko, Neil J. Press, Jeffrey P. Stonehouse, Alan Armstrong · 2015 · Organic Letters
  14. Vibralacton als Sonde zur Aufklärung der Aktivität und Struktur des ClpP1P2‐Komplexes aus Listeria monocytogenes
    Evelyn Zeiler, Nathalie Braun, Thomas Böttcher, Andreas Kastenmüller, Sevil Weinkauf, Stephan A. Sieber · 2011 · Angewandte Chemie
  15. A small molecule regulator of tissue transglutaminase conformation inhibits the malignant phenotype of cancer cells
    William P. Katt, Nicolas J. Blobel, Svetlana V. Komarova, Marc A. Antonyak, Ichiro Nakano, Richard A. Cerione · 2018 · Oncotarget
  16. Docking Ligands into Flexible and Solvated Macromolecules. 8. Forming New Bonds─Challenges and Opportunities
    Anne Labarre, Julia K. Stille, Mihai Burai Patrascu, Andrew Martins, Joshua Pottel, Nicolas Moitessier · 2022 · Journal of Chemical Information and Modeling
  17. Landscape of In Silico Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery
    Md. Nazmul Hasan, Manisha Ray, Arjun Saha · 2023 · The Journal of Physical Chemistry B
  18. Ferrous Iron-Dependent Delivery Of Therapeutic Agents To The Malaria Parasite
    Sumit S Mahajan, Jiří Gut, Philip Jon Rosenthal, Adam R. Renslo · 2012 · Future Medicinal Chemistry
  19. Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors
    Steffen Bugge, Ingri Ullestad Moen, Kent-Ove Kragseth Sylte, Eirik Sundby, Bård Helge Hoff · 2015 · European Journal of Medicinal Chemistry
  20. Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach
    Lin Du, Samantha S. Yee, Ramachandran Karthik, April L. Risinger · 2020 · Nature Communications
  21. Kinetic mechanisms of covalent inhibition
    Claire L. McWhirter · 2021 · Annual reports in medicinal chemistry
  22. Antibiotic activity and target discovery of three-membered natural product-derived heterocycles in pathogenic bacteria
    Maximilian Pitscheider, Nina Mäusbacher, Stephan A. Sieber · 2012 · Chemical Science
  23. Rapid and scalable synthesis of chiral bromolactones as precursors to α-exo-methylene-γ-butyrolactone-containing sesquiterpene lactones
    Roman Lagoutte, Miryam Pastor, Mathéo Berthet, Nicolas Winssinger · 2018 · Tetrahedron
  24. Modular Synthesis of Novel Macrocycles Bearing α,β‐Unsaturated Chemotypes through a Series of One‐Pot, Sequential Protocols
    Salim Javed, Bodugam Mahipal, Jessica Torres, Arghya Ganguly, Paul R. Hanson · 2016 · Chemistry - A European Journal
  25. Structure-based design of covalent inhibitors targeting metallo-β-lactamases
    Cheng Chen, Ke‐Wu Yang · 2020 · European Journal of Medicinal Chemistry
  26. Discovery and biological evaluation of 1-{2,7-diazaspiro[3.5]nonan-2-yl}prop-2-en-1-one derivatives as covalent inhibitors of KRAS G12C with favorable metabolic stability and anti-tumor activity
    Tomoyoshi Imaizumi, Michinori Akaiwa, Tomoaki Abe, Takahiro Nigawara, Takanori Koike, Yoshiki Satake, Kazushi Watanabe, Osamu Kaneko, Y. Amano, Kenichi Mori et al. · 2022 · Bioorganic & Medicinal Chemistry
  27. Structure‐Guided Drug Design Targeting Abl Kinase: How Structure and Regulation Can Assist in Designing New Drugs
    Diego Magno Martins, Philipe Oliveira Fernandes, Lucas A. Vieira, Vinícius Gonçalves Maltarollo, Adolfo Henrique Moraes · 2024 · ChemBioChem
  28. Targeting cysteine protease B to discover antileishmanial drugs: Directions and advances
    Éric de Oliveira Rios, Sonaly Lima Albino, Ricardo Olímpio de Moura, Igor José dos Santos Nascimento · 2025 · European Journal of Medicinal Chemistry
  29. Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase
    Cheng-Han Yu, Chi‐Chi Chou, Hsin-Fang Tu, Wei-Chieh Huang, Ya-Yeh Ho, Kay‐Hooi Khoo, Ming‐Shyue Lee, Geen‐Dong Chang · 2018 · Oncotarget
  30. Acetylation of the Catalytic Lysine Inhibits Kinase Activity in PI3Kδ
    Julie C. L. Fournier, John P. Evans, Francesca Zappacosta, Daniel A. Thomas, Vipulkumar K. Patel, Gemma V. White, Sébastien Campos, Nicholas C. O. Tomkinson · 2021 · ACS Chemical Biology
  31. Activity-Based Probes for Proteases Pave the Way to Theranostic Applications
    Georgia Sotiropoulou, Eleni Zingkou, Evangelos Bisyris, Georgios Pampalakis · 2022 · Pharmaceutics
  32. Optimization and characterization of a triazole urea dual inhibitor for lysophospholipase 1 (LYPLA1) and lysophospholipase 2 (LYPLA2)
    Alexander Adibekian, Brent R. Martin, Anna E Speers, Steven J Brown, Timothy Spicer, Virneliz Fernández-Vega, Jill Ferguson, Benjamin F. Cravatt, Peter Hodder, Hugh Rosen · 2013 · Europe PMC (PubMed Central)
  33. Combinatorially Screened Peptide as Targeted Covalent Binder: Alteration of Bait-Conjugated Peptide to Reactive Modifier
    Shuta Uematsu, Yudai Tabuchi, Yuji Ito, Masumi Taki · 2018 · Bioconjugate Chemistry
  34. Antibacterial Properties and Carbonic Anhydrase Inhibition Profiles of Azido Sulfonyl Carbamate Derivatives
    Pınar Güller, Ufuk Atmaca, Uğur Güller, Ulaş Çalışır, Feray Şenel Dursun · 2021 · Future Medicinal Chemistry
  35. Ectopic suicide inhibition of thioredoxin glutathione reductase
    Ilaria Silvestri, Haining Lyu, Francesca Fata, Paul R. Banta, Benedetta Mattei, Rodolfo Ippoliti, Andrea Bellelli, Giuseppina Pitari, Matteo Ardini, Valentina Z. Petukhova et al. · 2019 · Free Radical Biology and Medicine
  36. High throughput glutathione and Nrf2 assays to assess chemical and biological reactivity of cysteine-reactive compounds
    Russell T. Naven, Sheila Kantesaria, Sashi Nadanaciva, Thomas Schroeter, Karen L. Leach · 2013 · Toxicology Research
  37. 2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody (PART 1A – Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis PART 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)
    Mike Baratta, Wenying Jian, Shawna Mae Hengel, Surinder Kaur, Jennifer Cunliffe, Jason Boer, Nicki Hughes, Sumit Kar, John F. Kellie, Yeoun Jin Kim et al. · 2024 · Bioanalysis
  38. Techniques and support materials for enzyme immobilization using Ugi multicomponent reaction: an overview
    Heshmatollah Sepahvand, Majid Momahed Heravi, Mahyar Saber, Seyyed Emad Hooshmand · 2021 · Journal of the Iranian Chemical Society
  39. Exploring the biological promiscuity of high-throughput screening hits through DFT calculations
    Ramona F. Curpan, Sorin I. Avram, Robert Vianello, Cristian Bologa · 2014 · Bioorganic & Medicinal Chemistry
  40. Single‐Protein‐Specific Redox Targeting in Live Mammalian Cells and C. elegans
    Alexandra Van Hall‐Beauvais, Yi Zhao, Daniel A. Urul, Marcus J. C. Long, Yimon Aye · 2018 · Current Protocols in Chemical Biology
  41. The novel visual cycle inhibitor (±)-RPE65-61 protects retinal photoreceptors from light-induced degeneration
    Yuhong Wang, Xiang Ma, Parthasarathy Muthuraman, Arun Raja, Aravindan Jayaraman, Konstantin E. Petrukhin, Christopher L. Cioffi, Jian‐xing Ma, Gennadiy P. Moiseyev · 2022 · PLoS ONE
  42. A chemoproteomic method for identifying cellular targets of covalent kinase inhibitors
    Ying-Chu Chen, Chao Zhang · 2016 · Genes & Cancer
  43. Small molecule inhibitors of anthrax edema factor
    Guan‐Sheng Jiao, Seongjin Kim, Mahtab Moayeri, April Thai, Lynne Cregar, Linda McKasson, Sean W. O'Malley, Stephen Howard Leppla, Alan T. Johnson · 2017 · Bioorganic & Medicinal Chemistry Letters
  44. Fragment-Based Discovery of Irreversible Covalent Inhibitors of Cysteine Proteases Using Chlorofluoroacetamide Library
    Chizuru Miura, Naoya Shindo, Kei Okamoto, Keiko Kuwata, Akio Ojida · 2020 · Chemical and Pharmaceutical Bulletin
  45. The Proteome‐Wide Potential for Reversible Covalency at Cysteine
    Kristine Senkane, Ekaterina V. Vinogradova, Radu M. Suciu, Vincent M. Crowley, Balyn W. Zaro, J. Michael Bradshaw, Ken A. Brameld, Benjamin F. Cravatt · 2019 · Angewandte Chemie
  46. PROTACting the kinome with covalent warheads
    Deep Rohan Chatterjee, Saumya Kapoor, Meenakshi Jain, Rudradip Das, Moumita Ghosh Chowdhury, Amit Shard · 2022 · Drug Discovery Today
  47. Covalent Inhibition of Serine β-Lactamases by Novel Hydroxamic Acid Derivatives
    Ronak R. Tilvawala, Rex F. Pratt · 2013 · Biochemistry
  48. A tag‐free collisionally induced fragmentation approach to detect drug‐adducted proteins by mass spectrometry
    T. Eric Ballard, Upendra P. Dahal, Andrew J. Bessire, Richard P. Schneider, Kieran F. Geoghegan, Alfin D. N. Vaz · 2015 · Rapid Communications in Mass Spectrometry
  49. From Catalytic Mechanism to Rational Design of Reversible Covalent Inhibitors of Serine and Cysteine Hydrolases
    Michael Shokhen, Michal Hirsch, Netaly Khazanov, Rachel Ozeri, Nurit Perlman, Tamar Traube, S. Vijayakumar, Amnon Albeck · 2014 · Israel Journal of Chemistry
  50. A patent review of FGFR4 selective inhibition in cancer (2007-2018)
    Àlvaro Quintanal-Villalonga, Irene Ferrer, Sonia Molina‐Pinelo, Luis G Paz-Ares · 2019 · Expert Opinion on Therapeutic Patents
  51. Discovery of a potent BRD4 PROTAC and evaluation of its bioactivity in breast cancer cell lines
    Junjie Hu, Jianming Yang, Runxuan Zhou, Ke Chen, Hongyun Zhao, Yirong Zhou · 2025 · Biochemical Pharmacology
  52. Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease
    Cécilia Hognon, Marco Marazzi, Cristina García‐Iriepa · 2022 · International Journal of Molecular Sciences
  53. Direct screening of a target-specific covalent binder: stringent regulation of warhead reactivity in a matchmaking environment
    Yudai Tabuchi, Takahito Watanabe, Riku Katsuki, Yuji Ito, Masumi Taki · 2021 · Chemical Communications
  54. On the Origin of the Different Reversible Characters of Salinosporamide A and Homosalinosporamide A in the Covalent Inhibition of the Human 20S Proteasome
    Natalia Serrano-Aparicio, Vicent Moliner, Katarzyna Świderek · 2021 · ACS Catalysis
  55. Nitro sulfonyl fluorides are a new pharmacophore for the development of antibiotics
    Corinne M. Sadlowski, Bora Park, Clarissa A. Borges, Subhamoy Das, Daniel Lucas Kerr, Maomao He, Hesong Han, Lee W. Riley, Niren Murthy · 2018 · Molecular Systems Design & Engineering
  56. Profiling nuclear cysteine ligandability and effects on nuclear localization using proximity labeling-coupled chemoproteomics
    Qianni Peng, Eranthie Weerapana · 2023 · Cell chemical biology
  57. TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis
    Fangyu Hu, Lingling Zhao, Junyu Wang, Xiaoying Li, Zixuan Xue, Yimeng Ma, Minghui Zheng, Chenglin Chen, Meiting Tong, Xiaohuan Guo et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  58. Synthesis, molecular modeling studies, ADME prediction of arachidonic acid carbamate derivatives, and evaluation of their acetylcholinesterase activity
    Tugce N. Kalin, Deryanur Kılıç, Fatma Arslan, Özlem Çolak, Alíye Altundaş · 2019 · Drug Development Research
  59. Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity
    Jeffrey G. Martin, Jennifer A. Ward, Felix Feyertag, Lu Zhang, Shalise M. Couvertier, Kevin M. Guckian, K. Huber, Douglas S. Johnson · 2021 · ChemBioChem
  60. Characterization and molecular docking study of cathepsin L inhibitory peptides (SnuCalCpIs) from Calotropis procera R. Br
    Chang Woo Kwon, Subin Yeo, Pahn‐Shick Chang · 2022 · Scientific Reports
  61. Construction of Covalent Bisubstrate Inhibitor of Protein Kinase Reacting with Cysteine Residue at Substrate-Binding Site
    Tanel Sõrmus, Darja Lavõgina, Anu Teearu, Erki Enkvist, Asko Uri, Kaido Viht · 2022 · Journal of Medicinal Chemistry
  62. Covalent drug – An emerging framework for targeted drug development
    Ritesh P. Bhole, Govinda O. Joshi, Harshad S. Kapare, Rupesh V. Chikhale, Somdatta Y. Chaudhari · 2024 · Results in Chemistry
  63. Vinyl sulfonamide synthesis for irreversible tethering via a novel α-selenoether protection strategy
    Gregory B. Craven, Dominic P. Affron, Philip N. Raymond, David J. Mann, Alan Armstrong · 2018 · MedChemComm
  64. Focusing on probe-modified peptides: a quick and effective method for target identification
    Huan Sun, Yan Ren, Weijie Hou, Lin Li, Fanqi Zeng, Sisi Li, Yongfen Ma, Xiao Liu, She Chen, Zhiyuan Zhang · 2016 · Chemical Communications
  65. Distinguishing the optimal binding mechanism of an E3 ubiquitin ligase: Covalent versus noncovalent inhibition
    Imane Bjij, Shama Khan, Pritika Ramharack, Driss Cherqaoui, Mahmoud E. S. Soliman · 2019 · Journal of Cellular Biochemistry
  66. Covalent Affibody‐Molecular Glue Drug Conjugate Nanoagent for Proximity‐Enabled Reactive Therapeutics
    Wenhui Gao, Xiaoyuan Yang, Qingrong Li, Yingchun Liu, Wei Huang, Xuelin Xia, Deyue Yan · 2025 · Advanced Science
  67. Cysteine-reactive chemical probes based on a modular 4-aminopiperidine scaffold
    Shalise M. Couvertier, Eranthie Weerapana · 2013 · MedChemComm
  68. Evolution of HCV NS3/4a Protease Inhibitors
    Nigel J. Liverton · 2019 · Topics in medicinal chemistry
  69. Discovery of potent, non-carbonyl inhibitors of fatty acid amide hydrolase (FAAH)
    Sumithra Gowlugari, Jeff DeFalco, Margaret T.L. Nguyen, Carl J. Kaub, Candace Chi, Matthew A. J. Duncton, Daniel E. Emerling, Michael G. Kelly, John Kincaid, Fabien Vincent · 2012 · MedChemComm
  70. Hydroxylammonium derivatives for selective active-site lysine modification in the anti-virulence bacterial target DHQ1 enzyme
    Marı́a Maneiro, Emilio Lence, Marta Sanz‐Gaitero, José M. Otero, Mark J. van Raaij, Paul Thompson, Alastair R. Hawkins, Concepción González‐Bello · 2019 · Organic Chemistry Frontiers
  71. Current Advances in the Synthesis and Biological Evaluation of Pharmacologically Relevant 1,2,4,5-Tetrasubstituted-1H-Imidazole Derivatives
    Renzo Rossi, Maurizio Ciofalo · 2019 · Current Organic Chemistry
  72. Design, synthesis, and in vitro evaluation of a fluorescently labeled irreversible inhibitor of the catalytic subunit of cAMP-dependent protein kinase (PKACα)
    Robert A. Coover, Nicole M. Luzi, Sudha Korwar, Maria E. Casile, Charles E. Lyons, Darrell L. Peterson, Keith C. Ellis · 2016 · Organic & Biomolecular Chemistry
  73. Sulfopin, a selective covalent inhibitor of Pin1, blocks Myc-driven tumor initiation and growth in vivo
    Christian Dubiella, Benika J. Pinch, Daniel Zaidman, Theresa D. Manz, Evon Poon, Shuning He, Efrat Resnick, Ellen M. Langer, Colin J. Daniel, Hyuk‐Soo Seo et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Computational Analysis of SMPD1 Mutants and Their Binding Affinity with Desipramine: A Therapeutic Insight into Niemann–Pick Disease Type A
    K. Priyanka, Madhana Priya N, Sidharth Kumar N, Vasundra V., Shiek S. S. J. Ahmed, Magesh Ramasamy · 2025 · ChemistrySelect
  75. Omuralid und Vibralacton: Unterschiede im Proteasom‐β‐Lacton‐γ‐Lactamgerüst verändern die Zielmolekülpräferenz
    Anja List, Evelyn Zeiler, Nerea Gallastegui, Marion Rusch, Christian Hedberg, Stephan A. Sieber, M. Groll · 2013 · Angewandte Chemie
  76. Molecular Characterization of Kunitz-Type Protease Inhibitors from Blister Beetles (Coleoptera, Meloidae)
    Emiliano Fratini, Marianna Nicoletta Rossi, Lucrezia Spagoni, Alessandra Riccieri, Emiliano Mancini, Fabio Polticelli, Marco Alberto Bologna, Paolo Mariottini, Manuela Cervelli · 2022 · Biomolecules
  77. Specific Chemical Modification of Bacterial Type I Dehydroquinase: Opportunities for Drug Discovery
    Concepción González‐Bello · 2015 · Future Medicinal Chemistry
  78. On-flow enzymatic inhibitor screening: The emerging success of liquid chromatography-based assays
    Pamella Christina Ortega de Oliveira, Renato Lessa, Millena Santana Ceroullo, Camila Anchau Wegermann, Marcela Cristina de Moraes · 2022 · Frontiers in Analytical Science
  79. Chemoproteomik‐vermittelte Entdeckung eines potenten und selektiven Inhibitors des DNA‐Reparaturproteins MGMT
    Chao Wang, Daniel Abegg, Dominic G. Hoch, Alexander Adibekian · 2016 · Angewandte Chemie
  80. Target identification reveals protein arginine methyltransferase 1 is a potential target of phenyl vinyl sulfone and its derivatives
    Cheng-Han Yu, Chi‐Chi Chou, Der‐Yen Lee, Kay‐Hooi Khoo, Geen‐Dong Chang · 2018 · Bioscience Reports
  81. Design of gossypetin derivatives based on naturally occurring flavonoid in Hibiscus sabdariffa and the molecular docking as antibacterial agents
    Nuzul Wahyuning Diyah, Isnaeni Isnaeni, Shabrina Wahyu Hidayati, Bambang Purwanto, Siswandono · 2021 · Journal of Basic and Clinical Physiology and Pharmacology
  82. Crystal structure of human 17beta-HSD type 1 in ternary complex with PBRM and NADP+
    Tang Li, S.X. Lin · 2018 · Worldwide Protein Data Bank
  83. Chemoproteomic Profiling of Clickable Fumarate Probes for Target Identification and Mechanism of Action Studies
    Lu Zhang, Jeffrey G. Martin, Benbo Gao, Weike Zeng, Shalise M. Couvertier, Douglas S. Johnson · 2025 · ACS Chemical Biology
  84. Kinetic Modeling of Covalent Inhibition: Effects of Rapidly Fluctuating Intermediate States
    Kyle Ghaby, Benoı̂t Roux · 2025 · Journal of Chemical Information and Modeling
  85. Quantitative Proteomics in Development of Disease Protein Biomarkers
    Xudong Yao, Adam J. McShane, Mary Joan Castillo · 2013 · Elsevier eBooks
  86. Recent progress in natural product-based inhibitor screening with enzymatic fluorescent probes
    Yi Chen · 2021 · Analytical Methods
  87. Understanding Cysteine Chemistry Using Conventional and Serial X-ray Protein Crystallography
    Nathan Smith, Mark A. Wilson · 2022 · Crystals
  88. There and Back Again: A Perspective on 20 Years of CYP4Z1
    John P. Kowalski, Allan E. Rettie · 2024 · Drug Metabolism and Disposition
  89. Identification of novel small molecule non-peptidomimetic inhibitor for prolyl oligopeptidase through in silico and in vitro approaches
    Apeksha Shrivastava, Shubham Srivastava, Ruchi Malik, Mohammad Mumtaz Alam, Mohammad Shaqiquzzaman, Mymoona Akhter · 2019 · Journal of Biomolecular Structure and Dynamics
  90. Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors**
    David Quach, Guanghui Tang, Jothi Anantharajan, Nithya Baburajendran, Anders Poulsen, John Liang Kuan Wee, Priya Retna, Rong Li, Bo Liu, Doris Hui Ying Tee et al. · 2021 · Angewandte Chemie
  91. On-site reaction for PPARγ modification using a specific bifunctional ligand
    Hiroyuki Kojima, Toshimasa Itoh, Keiko Yamamoto · 2017 · Bioorganic & Medicinal Chemistry
  92. Targeted but Troubling: CYP450 Inhibition by Kinase and PARP Inhibitors and Its Clinical Implications
    Martin Kondža, Josipa Bukić, Ivan Ćavar, Biljana Tubić · 2025 · Drugs and Drug Candidates
  93. Benzimidazole covalent probes and the gastric H+/K+-ATPase as a model system for protein labeling in a copper-free setting
    Chelsea Paresi, Qi Liu, Yue‐Ming Li · 2016 · Molecular BioSystems
  94. Fluoromethylketone‐Fragment Conjugates Designed as Covalent Modifiers of Ec DsbA are Atypical Substrates
    B.C. Doak, Rebecca L. Whitehouse, Kieran A. Rimmer, Martin L Williams, Begoña Heras, Sofia Caria, Olga V. Ilyichova, Mansha Vazirani, Biswaranjan Mohanty, Jason Brian Harper et al. · 2024 · ChemMedChem
  95. Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor
    Zhenfei Zhou, Siqi Huang, Shijie Fan, Xueyuan Li, Chengyu Wang, W. Yu, Daohai Du, Yuanyuan Zhang, Kaixian Chen, Wei Fu et al. · 2024 · Journal of Medicinal Chemistry
  96. Covalent Chemical Cochaperones of the p300/CBP GACKIX Domain
    Jean M. Lodge, Chinmay Y. Majmudar, James Clayton, Anna K. Mapp · 2018 · ChemBioChem
  97. High performance liquid chromatographic assays with UV-detection for evaluation of inhibitors of acetylcholinesterase and butyrylcholinesterase
    Giulia Michels, Matthias Lehr · 2021 · Journal of Liquid Chromatography & Related Technologies
  98. Comparison of irreversible inhibition targeting HSP72 protein: the resurgence of covalent drug developments
    Aimen Aljoundi, Ahmed Abd Elkader El-Rashedy, Mahmoud E. S. Soliman · 2021 · Molecular Simulation
  99. A new method for filtering of reactive “warheads” of transition-state analog protease inhibitors
    Tamar Traube, Michael Shokhen, Amnon Albeck · 2014 · European Journal of Medicinal Chemistry
  100. Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors
    Letitia Shunmugam, Pritika Ramharack, Mahmoud E. S. Soliman · 2017 · The Protein Journal